7th Genome Editing Therapeutics Summit – Boston, Massachusetts
11 11 people viewed this event.
The FDA has shown its’ hand. The Plausible Mechanism Framework and new NGS safety guidance signal one thing clearly: regulators want genome editing therapies to reach patients. Biopharma are also pushing back with a surge of novel genome editing assets deployed in the last 2 years, targeting rare and prevalent diseases with scarce treatment options.
Date and Time: Tuesday, 29 September 2026 at 08:00 – Wednesday, 30 September 2026 at 17:00
Venue details: Hilton Boston Logan Airport, One Hotel Drive, Boston, Massachusetts, 02128, United States
Prices:
USD 0.00 – USD 3899.00
Event Organizer - Hanson Wade
Contact Name - Isobel Slater
Email - info@hansonwade.com